Nutraceutical Potential of Bitter Melon (<i>Momordica charantia</i>) on Cancer Treatment: An Overview of In Vitro and Animal Studies. [PDF]
Deligiannidou GE +6 more
europepmc +1 more source
Bitter Melon Powder Enhances Antioxidant Capacity, Muscle Nutrition, and Glucolipid Metabolic Homeostasis in <i>Cyprinus carpio</i> Fed High-Starch Diets. [PDF]
Zhang Y +7 more
europepmc +1 more source
In Vitro and In Vivo Evaluation of Rosuvastatin and Momordica charantia (Bitter Melon) Extract: Pharmacokinetic Interactions and Anticancer Potential. [PDF]
Akeel R +8 more
europepmc +1 more source
Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies. [PDF]
Hussain L +7 more
europepmc +1 more source
Exploring the Antidiabetic and Antihypertensive Potential of Peptides Derived from Bitter Melon Seed Hydrolysate. [PDF]
Hung WT +4 more
europepmc +1 more source
Preparation, Characterization, and Safety Evaluation of a Submicron Emulsion Processed Using High-Pressure Homogenization to Protect Bitter Melon Seed Oil. [PDF]
Wang H +7 more
europepmc +1 more source
Transcriptome and metabolome changes induced by bitter melon (<i>Momordica charantia</i>)- intake in a high-fat diet induced obesity model. [PDF]
Reed D +13 more
europepmc +1 more source
Enhancing the medicinal properties and phytochemical content of bitter melon (Momordica charantia L.) through elicitation with brassinosteroid, ethrel, and carrageenan. [PDF]
Mohkami Z +5 more
europepmc +1 more source
Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy. [PDF]
Sur S, Ray RB.
europepmc +1 more source

